stockrow
Friday 6 November 2026
Export ALGN’s income statement to Excel — free account
Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.
- Revenue
- +1.92%
- EPS
- +143.9%
- Free cash flow
- +8.26%
Quarter to September 2026, against a year earlier
160.79
1.42
+0.89%
Follow ALGN
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
40.74 | 77.72 | 41.89 | 50.10 | 23.66 | 67.20 | 45.95 | 46.13 | 37.10 | 27.59 |
Piotroski F-Score |
7 | 6 | 7 | 6 | 5 | 6 | 5 | 7 | 7 | 6 |
Altman Z-Score |
13.50 | 19.09 | 14.91 | 13.76 | 17.37 | 15.36 | 5.91 | 6.74 | 5.58 | 4.73 |
P/S ratio |
7.17 | 12.21 | 8.53 | 9.21 | 17.03 | 13.12 | 4.44 | 5.32 | 3.90 | 2.81 |
P/FCF ratio |
43.73 | 74.08 | 50.60 | 37.09 | 82.97 | 67.23 | 59.96 | 33.80 | 25.07 | 23.08 |
Altman Z″-Score (non-manufacturers) |
6.93 | 6.17 | 5.72 | 4.99 | 4.87 | 4.81 | 4.29 | 3.99 | 4.15 | 4.56 |
Beneish M-Score |
(2.34) | (2.82) | (2.67) | (2.95) | 0.45 | (2.49) | (2.67) | (2.71) | (2.61) | (2.52) |
P/Operating CF |
95.61 | 110.82 | 69.49 | 101.58 | 110.35 | 190.08 | 114.70 | 438.24 | 54.57 | 50.76 |
P/B ratio |
7.78 | 15.58 | 13.38 | 16.46 | 13.01 | 14.32 | 4.61 | 5.66 | 4.05 | 2.80 |
Price to Tangible BV |
8.48 | 16.89 | 14.32 | 17.44 | 15.83 | 16.76 | 5.36 | 6.57 | 4.72 | 3.27 |
EV/Sales |
6.58 | 11.72 | 8.15 | 8.85 | 16.64 | 12.82 | 4.18 | 5.07 | 3.64 | 2.54 |
EV/EBITDA |
26.02 | 44.12 | 30.76 | 34.26 | 85.55 | 46.71 | 20.30 | 24.92 | 19.36 | 13.07 |
EV/Operating CF |
28.68 | 39.37 | 28.90 | 28.50 | 62.11 | 43.23 | 27.43 | 24.92 | 19.73 | 17.25 |
EV/FCF |
40.11 | 71.10 | 48.38 | 35.63 | 81.08 | 65.71 | 56.35 | 32.20 | 23.40 | 20.85 |
Quick Ratio |
2.51 | 2.09 | 1.70 | 1.46 | 1.22 | 1.08 | 0.97 | 0.91 | 1.00 | 1.14 |
Current Ratio |
2.69 | 2.32 | 1.88 | 1.68 | 1.40 | 1.30 | 1.26 | 1.18 | 1.22 | 1.36 |
Net Debt/EBITDA |
(2.35) | (1.84) | (1.41) | (1.40) | (2.00) | (1.08) | (1.30) | (1.24) | (1.39) | (1.40) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.85 | 0.93 | 1.03 | 1.06 | 0.67 | 0.73 | 0.63 | 0.64 | 0.65 | 0.65 |
Operating CF/Net income |
1.31 | 1.90 | 1.39 | 1.69 | 0.37 | 1.52 | 1.57 | 1.77 | 1.75 | 1.45 |
Capex/Depreciation |
(2.94) | (5.19) | (4.08) | (1.90) | (1.66) | (3.69) | (2.32) | (1.25) | (0.80) | (0.43) |
| 20.58% | 21.53% | 33.25% | 34.07% | 77.55% | 22.52% | 10.01% | 12.31% | 11.26% | 10.39% | |
| 14.85% | 14.55% | 20.86% | 19.45% | 48.45% | 14.33% | 6.08% | 7.40% | 6.85% | 6.59% | |
ROIC |
43.81% | 51.07% | 56.34% | 71.00% | 10.65% | 24.89% | 15.44% | 15.13% | 13.52% | 11.55% |
Return on Tangible Assets |
24.51% | 22.98% | 35.36% | 34.21% | 141.09% | 46.73% | 20.90% | 26.64% | 24.42% | 22.45% |
Average Days of Receivables |
83.63 | 80.31 | 81.48 | 83.45 | 97.11 | 82.85 | 84.02 | 85.38 | 90.88 | 99.66 |
Research and Development Expense of Revenue |
7.01% | 6.62% | 6.55% | 6.54% | 7.09% | 6.33% | 8.17% | 8.98% | 9.11% | 9.17% |
Selling, General and Administrative Expense of Revenue |
45.44% | 45.19% | 43.35% | 44.54% | 48.58% | 43.23% | 44.84% | 44.10% | 44.09% | 43.51% |
Intangible Assets out of Total Assets |
0.06 | 0.05 | 0.04 | 0.03 | 0.12 | 0.09 | 0.08 | 0.08 | 0.09 | 0.09 |
Share Based Compensation of Revenue |
5.01% | 3.99% | 3.60% | 3.66% | 3.98% | 2.89% | 3.57% | 3.99% | 4.34% | 4.61% |
Graham Net Nets |
0.07 | 0.03 | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
Graham Number |
25.84 | 30.61 | 41.96 | 46.09 | 144.46 | 100.51 | 69.19 | 78.94 | 80.65 | 84.31 |
Earnings Yield |
2.45% | 1.29% | 2.39% | 2.00% | 4.23% | 1.49% | 2.18% | 2.17% | 2.70% | 3.62% |
Free Cash Flow Yield |
2.29% | 1.35% | 1.98% | 2.70% | 1.21% | 1.49% | 1.67% | 2.96% | 3.99% | 4.33% |
Revenue per Share |
13.52 | 18.40 | 24.56 | 30.30 | 31.39 | 50.09 | 47.76 | 50.54 | 53.41 | 55.62 |
Operating CF per Share |
3.10 | 5.48 | 6.93 | 9.41 | 8.41 | 14.86 | 7.27 | 10.28 | 9.86 | 8.18 |
Capex per Share |
(0.88) | (2.44) | (2.79) | (1.88) | (1.97) | (5.08) | (3.73) | (2.33) | (1.54) | (1.41) |
Free Cash Flow per Share |
2.22 | 3.03 | 4.14 | 7.52 | 6.44 | 9.78 | 3.54 | 7.96 | 8.32 | 6.77 |
Cash per Share |
8.02 | 9.01 | 9.18 | 10.94 | 12.20 | 14.84 | 12.78 | 12.73 | 13.94 | 15.09 |
Shareholders Equity per Share |
12.46 | 14.41 | 15.65 | 16.95 | 41.06 | 45.91 | 46.06 | 47.50 | 51.44 | 55.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
12.46 | 14.41 | 15.65 | 16.95 | 41.06 | 45.91 | 46.06 | 47.50 | 51.44 | 55.82 |
Free Cash Flow |
177.08 | 242.84 | 331.37 | 597.56 | 507.26 | 771.45 | 276.83 | 608.06 | 622.65 | 490.78 |
Working Capital |
598.64 | 658.32 | 610.41 | 662.45 | 523.94 | 570.00 | 498.50 | 380.01 | 454.41 | 696.55 |
Capital Expenditures |
(70.58) | (195.69) | (223.31) | (149.71) | (154.92) | (401.10) | (291.90) | (177.72) | (115.58) | (102.44) |
Net Current Asset Value |
552.22 | 528.65 | 502.91 | 478.89 | 253.72 | 174.68 | 77.80 | (6.77) | 129.83 | 432.02 |
EV/EBIT |
28.53 | 48.83 | 34.36 | 39.25 | 106.22 | 51.92 | 24.27 | 30.43 | 23.98 | 18.75 |
Capex to Sales |
0.07 | 0.13 | 0.11 | 0.06 | 0.06 | 0.10 | 0.08 | 0.05 | 0.03 | 0.03 |
Price to Operating Income |
31.11 | 50.87 | 35.94 | 40.85 | 108.71 | 53.12 | 25.83 | 31.95 | 25.69 | 20.76 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.11 | 0.11 | 0.13 | 0.13 | 0.10 | 0.10 | 0.11 | 0.11 | 0.21 |
Cash ROIC |
10.83% | 12.95% | 16.67% | 26.98% | 12.09% | 16.09% | 6.02% | 13.21% | 12.72% | 9.54% |
Accounts Receivable Turnover |
5.32 | 5.16 | 5.15 | 4.87 | 4.09 | 5.08 | 4.25 | 4.38 | 4.21 | 3.85 |
Accounts Payable Turnover |
8.41 | 10.91 | 10.27 | 8.75 | 6.18 | 6.65 | 7.55 | 9.59 | 10.82 | 11.51 |
Inventory Turnover |
11.36 | 12.12 | 11.88 | 7.91 | 5.64 | 5.51 | 3.87 | 3.64 | 4.35 | 5.51 |
Average Days of Payables |
39.45 | 37.66 | 45.22 | 48.04 | 73.20 | 58.81 | 42.40 | 35.74 | 33.06 | 33.48 |
Days of Inventory on Hand |
37.43 | 32.45 | 39.16 | 61.70 | 71.71 | 82.61 | 112.32 | 93.79 | 77.36 | 62.40 |
Average Receivables |
202.98 | 285.80 | 381.60 | 494.65 | 604.00 | 777.45 | 878.44 | 881.55 | 949.55 | 1,048.72 |
Average Payables |
31.48 | 32.69 | 50.52 | 75.75 | 114.69 | 153.01 | 145.88 | 120.50 | 110.91 | 115.07 |
Average Inventory |
23.30 | 29.41 | 43.66 | 83.85 | 125.64 | 184.73 | 284.49 | 317.83 | 275.59 | 240.32 |
Average Assets |
1,277.39 | 1,590.08 | 1,918.23 | 2,276.58 | 3,665.19 | 5,385.90 | 5,945.03 | 6,015.91 | 6,149.24 | 6,224.15 |
Average Common Equity |
921.66 | 1,074.84 | 1,203.59 | 1,299.53 | 2,290.02 | 3,428.29 | 3,612.04 | 3,615.92 | 3,741.24 | 3,950.57 |
Columns are period end dates · fundamentals updated 2 Nov 2026